Aurobindo Pharma Ltd Annually Results

Gross Sales

31,378.13

28,704.5

24,617.13

23,366.55

24,557.95

Excise Duty

0

0

0

0

0

Net Sales

31,378.13

28,704.5

24,617.13

23,366.55

24,557.95

Other Operating Income

345.6

297.37

238.25

88.94

216.68

Other Income

621.85

557.38

290.59

320.35

3,195.42

Total Income

32,345.58

29,559.25

25,145.97

23,775.84

27,970.05

Total Expenditure

25,172.63

23,367.89

21,148.41

19,227.94

19,496.58

PBIDT

7,172.95

6,191.36

3,997.56

4,547.9

8,473.47

Interest

457.24

289.71

140.48

48.64

74.49

PBDT

6,715.71

5,901.65

3,857.08

4,499.26

8,398.98

Depreciation

1,649.42

1,521.66

1,244.58

1,126.52

1,055.38

Minority Interest Before NP

0

0

0

0

0

Tax

1,699.98

1,777.54

1,071.48

662.82

2,321.82

Deferred Tax

-117.26

-566.52

-386.63

62.81

-312.05

Reported Profit After Tax

3,483.57

3,168.97

1,927.65

2,647.11

5,333.83

Minority Interest After NP

-2.31

-4

0.15

-1.04

-1.02

Net Profit after Minority Interest

3,485.88

3,172.97

1,927.5

2,648.15

5,334.85

Extra-ordinary Items

0

-114

0

-100.44

1,924.7

Adjusted Profit After Extra-ordinary item

3,485.88

3,286.97

1,927.5

2,748.59

3,410.15

EPS (Unit Curr.)

59.81

54.16

32.9

45.19

91.04

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

450

300

900

400

Equity

58.08

58.59

58.59

58.59

58.59

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

22.85

21.56

16.23

19.46

34.5

PBDTM(%)

21.4

20.56

15.66

19.25

34.2

PATM(%)

11.1

11.03

7.83

11.32

21.71